Global Irritable Bowel Syndrome Treatment Market 2018 Scope Overview and Regional Trends By 2026


The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life.
However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.

Some major players operating in the irritable bowel syndrome treatment market are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.

Request Sample Copy Of This Research Report:

Market Dynamics
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.

Detailed Segmentation:
Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
Lubiprostone, Linaclotide
Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
IBS-Constipation, IBS-Diarrhea
Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
Hospital Pharmacies
Global Irritable Bowel Syndrome Treatment Market, By Geography:
North America, Europe, Asia-Pacific, Latin America, Middle East
Africa

Market Taxonomy
This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.

Key features of the study:
This report provides in-depth analysis of irritable bowel syndrome treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global irritable bowel syndrome treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans


About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Comments

Post a Comment

Popular posts from this blog

Medical Automation Market Analysis, Growth, Size, Share, Trends, Supply Demand and Forecast to 2026

Medical automation is a technology used to minimize medical errors, promote better management of chronic illness, and to enable healthcare professionals to anticipate prognosis. It controls the diagnostic, monitoring, and therapeutic machineries that serves the major responsive tasks into the hospitals. It also increases the predictability of outcome when patients follow a standardized care path supported by automation. Moreover, automation can help to detect when a patient has deviated from recommended care plan so the care team can intervene. The technology implementation enhances efficiency of hospitals by reducing the process time and improving accuracy of a medical procedures. Medical automation in hospitals such as using robotic assisted systems for health check-ups, is also propelling the growth of the market and in turn improving patient safety. Hospitals are adopting the medical robotics to reduce the HAIs rates in healthcare facility and to provide cleaner and saf...
Read more

Medical Disposables Market to Witness a Pronounce Growth by 2026

Medical disposables are products that are used in hospitals or in various medical fields for prevention of infections and for safety measures to meet the medical standards. The medical disposables are important to lower the risk of cross-contamination and infections that is a primary aim of healthcare professionals and governments globally. Medical disposables includes conventional syringes, disposable medical catheters, isolation gowns, procedure kits and trays, blood glucose tes t strips, and wound care products. The medical disposables are the essential component of every hospital and they have one time usage and need to be disposed after use. Medical disposables are used in surgery, drug and fluid delivery, wound management, diagnostic testing, patient examination, incontinence management, sterilization, and to reduce the discomfort of patient. The need of safety and prevention from infections for the various medical fields such as surgical wear, hygiene, anesthesia and ped...
Read more

Venipuncture Needle and Syringes Market Size, Future Forecast, Key Manufactures And Industrial Opportunities To 2026

Venipuncture is a perforation on a vein as part of a medical practice, basically to draw a blood sample and or to inject a drug into the body. This is done by intravenous cannulation. The venipuncture blood collection is carried out with the help of needle and syringes. Venipuncture is the oldest invasive procedures, which is carried out for five basic reasons and they are to collect blood for investigative purposes, identify the levels of blood components, and administer medications, nutrition, or chemotherapy, to eliminate blood due high presence of iron or erythrocytes and to collect blood which might be useful later in transfusion purpose. This can be possibly done with the use of venipuncture needle and with the immense increase in the blood test and blood collection, there is a proportional increase in the venipuncture needle and syringe market. Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/176 Excessive blood withdrawn may le...
Read more